Ethisterone, also known by its trade names Pranone,
Proluton C, and Lutocyclin, is a synthetic progestogen that has been utilized for a variety of medical indications. As a derivative of
testosterone, it belongs to the class of progestins, which mimic the activity of the naturally occurring hormone
progesterone. Developed in the early 20th century, ethisterone was one of the first orally active progestogens introduced into clinical practice. It was initially researched and manufactured by pharmaceutical companies such as
Schering AG. The drug has been indicated for several conditions, including
menstrual disorders,
endometriosis, and
menopausal symptoms. Despite its historical significance, modern alternatives with improved safety profiles and efficacy have largely superseded ethisterone, limiting its contemporary use.
Ethisterone's mechanism of action primarily revolves around its ability to bind to
progesterone receptors in the body, simulating the natural effects of progesterone. Once administered, ethisterone interacts with these receptors in the uterus, mammary glands, and brain, among other tissues. By doing so, it stabilizes the endometrial lining, preventing the proliferative action of estrogen and reducing menstrual bleeding. This is particularly beneficial for conditions like endometriosis, where the reduction in endometrial tissue proliferation can alleviate
pain and other symptoms. Additionally, ethisterone helps counteract
estrogen’s effects in the breast tissue, which can be beneficial in treating certain hormone-sensitive conditions.
Ethisterone can be administered orally in the form of tablets. The dosing regimen typically depends on the specific condition being treated. For menstrual disorders, a common dosing schedule would involve taking the medication on specific days of the menstrual cycle. The onset of action varies with the condition being treated and the individual’s response to the drug, but therapeutic effects are generally observed within a few days to a week of starting the medication. It is crucial to follow the prescribed dosing schedule and not to discontinue the drug abruptly without consulting a healthcare provider, as doing so can precipitate a recurrence of symptoms.
Like all medications, ethisterone comes with a range of potential side effects. Common adverse effects include
nausea,
headache,
breast tenderness, and
mood changes. These side effects are often mild and may resolve as the body adjusts to the medication. However, there are more severe risks, such as
thromboembolic events (
blood clots),
cardiovascular issues, and liver dysfunction. These serious side effects underscore the importance of careful patient selection and monitoring during treatment. Contraindications for the use of ethisterone include a history of thromboembolic disorders, severe
liver disease, known or suspected
malignancy in hormone-sensitive tissues, and undiagnosed
vaginal bleeding. Patients with a history of
depression or other mental health issues should also be monitored closely, as progestogens can exacerbate these conditions.
Ethisterone’s effectiveness and safety can be influenced by interactions with other medications. For instance, enzyme-inducing drugs such as
rifampicin,
phenytoin, and
carbamazepine can accelerate the metabolism of ethisterone, reducing its efficacy. Concurrent use of these medications may necessitate dose adjustments or the selection of alternative therapies. On the other hand, certain drugs like
ketoconazole and
erythromycin can inhibit the metabolism of ethisterone, potentially increasing its plasma concentration and the risk of side effects. Additionally, caution is advised when using ethisterone with other hormonal therapies, as this can lead to unpredictable hormonal fluctuations and side effects. Patients should always inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to ensure safe and effective use of ethisterone.
In conclusion, ethisterone has played a significant role in the history of hormone therapy and remains an important drug in understanding the development of synthetic progestogens. Its mechanism of action, involving the stabilization of the endometrial lining and counteracting estrogen’s effects, makes it useful in treating various gynecological conditions. However, the potential for side effects and drug interactions necessitates careful patient selection and monitoring. While ethisterone may not be the first-line therapy in modern clinical practice, its contributions to the field of endocrinology are enduring.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


